ADMA - ADMA BIOLOGICS, INC.
16.54
0.160 0.967%
Share volume: 8,245,421
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$16.38
0.16
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-07-2024 | 03-18-2025 | 05-07-2025 | 08-06-2025 | 11-05-2025 | 02-25-2026 | |
| Total revenue | 81.875 M | 107.191 M | 119.839 M | 117.549 M | 114.802 M | 121.984 M | 134.224 M | 139.163 M | |
| Cost of revenue | 42.767 M | 49.738 M | 60.180 M | 54.216 M | 53.705 M | 54.757 M | 58.598 M | 50.348 M | |
| Gross profit | 39.108 M | 57.453 M | 59.659 M | 63.333 M | 61.097 M | 67.227 M | 75.626 M | 88.815 M | |
| 46.91% | 3.84% | 6.16% | -3.53% | 10.03% | 12.49% | 17.44% | |||
| Operating expenses | 17.094 M | 18.110 M | 19.993 M | 24.985 M | 26.191 M | 24.397 M | 24.576 M | 26.014 M | |
| Selling general and admin | 16.644 M | 17.550 M | 19.581 M | 24.594 M | 25.365 M | 23.366 M | 23.048 M | 24.637 M | |
| Research and development | 450.000 K | 560.000 K | 412.000 K | 391.000 K | 826.000 K | 1.031 M | 1.528 M | 1.377 M | |
| Total expenses | 17.287 M | 18.252 M | 20.021 M | 25.010 M | 26.216 M | 24.429 M | 24.614 M | 26.063 M | |
| 5.58% | 9.69% | 24.92% | 4.82% | -6.82% | 0.76% | 5.89% | |||
| Operating income | 21.821 M | 39.201 M | 39.638 M | 38.323 M | 34.881 M | 42.798 M | 51.012 M | 62.752 M | |
| Ebit | 21.786 M | 39.185 M | 39.582 M | 38.237 M | 34.817 M | 42.690 M | 50.991 M | 62.733 M | |
| Pretax income | 18.401 M | 35.851 M | 36.749 M | 34.713 M | 33.450 M | 40.097 M | 47.515 M | 61.594 M | |
| 94.83% | 2.50% | -5.54% | -3.64% | 19.87% | 18.50% | 29.63% | |||
| Income tax | 595.000 K | 3.789 M | 840.000 K | -77.183 M | 6.546 M | 5.878 M | 11.087 M | 12.215 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 17.806 M | 32.062 M | 35.909 M | 111.896 M | 26.904 M | 34.219 M | 36.428 M | 49.379 M | |
| 80.06% | 12.00% | 211.61% | -75.96% | 27.19% | 6.46% | 35.55% |